CXCR4 and breast cancer: It was concluded that the mechanism of CXCL12 associated BRN is controlled by the inhibition of complex targets such as CXCL12/CXCR4, PDZK1 and PI3k/Akt to obtain new biological insight to treat metastatic BC.